跳至主要内容
临床试验/IRCT20120215009014N414
IRCT20120215009014N414招募中3 期

Effect of coenzyme Q10 versus placebo on the prevention of contrast medium-induced nephropathy in patients undergoing primary angioplasty: a double-blind randomized clinical trial

Hamedan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Age 18 to 75 years;
  • Symptoms of persistent myocardial ischemia for at least 30 minutes;
  • Less than 12 hours after the onset of heart attack symptoms;
  • Increased ST segment on electrocardiogram;
  • Treated with primary angioplasty;

排除标准

  • Consumption of any antioxidants in the past month;
  • Indication of cardiac bypass surgery;
  • History of myocardial infarction or angioplasty;
  • Indication of thrombolytic therapy;
  • Cardiogenic shock;
  • History of heart failure;
  • Advanced liver failure or autoimmune or inflammatory diseases

研究者

相似试验

Effect of coenzyme Q10 versus placebo on the... | 临床试验